Abstract
Streptococcus pneumoniae has been a rare cause of endocarditis in the postantibiotic era. The emergence of antibiotic-resistant Pneumococcus species has been accompanied by isolated reports of penicillin-resistant S. pneumoniae (PRSP) endocarditis. We report a case of bivalvular PRSP endocarditis that was treated with vancomycin and trovafloxacin, and we review the literature on this topic.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Infective Agents / therapeutic use
-
Endocarditis, Bacterial / drug therapy*
-
Female
-
Fluoroquinolones*
-
Humans
-
Middle Aged
-
Naphthyridines / therapeutic use
-
Penicillin Resistance
-
Pneumococcal Infections / drug therapy*
-
Streptococcus pneumoniae / drug effects*
-
Vancomycin / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Anti-Infective Agents
-
Fluoroquinolones
-
Naphthyridines
-
Vancomycin
-
trovafloxacin